Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of gastrodin to preparation of medicine for protecting human umbilical vein endothelial cells

A technology of vascular endothelium and umbilical vein, applied in the field of cell biology and pharmacology, can solve the problems of unreported hypertension and achieve the effect of small side effects, good effect and low dosage

Inactive Publication Date: 2018-04-20
CHINA PHARM UNIV
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It mainly includes gastrodin, gastrodin aglycon and gastrodia elata polysaccharide, etc., but there is no report on the treatment of hypertension caused by homocysteine ​​pathogenesis with gastrodin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of gastrodin to preparation of medicine for protecting human umbilical vein endothelial cells
  • Application of gastrodin to preparation of medicine for protecting human umbilical vein endothelial cells
  • Application of gastrodin to preparation of medicine for protecting human umbilical vein endothelial cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] The establishment of embodiment 1 cell damage model

[0017] Grouping: The experiment was divided into a blank group, a control group, and a different concentration of Hcy group; each group had 5 replicate wells.

[0018] Cell model establishment:

[0019] (1) Collect HUVEC cells in the logarithmic phase. After the cells are 90% full, aspirate the original medium, add 150 μL of Hcy solution with different concentrations in the experimental group, add 150 μL of medium in the control group and blank group, and the final volume of each well is 150 μL.

[0020] (2) Place in 5% CO2, 37°C cell culture incubator and incubate for 6, 12, 18, 24, 30 h, observe under an inverted microscope; add 20 μL of MTT solution to each well, and continue culturing in a 37°C constant temperature incubator for 4 h.

[0021] (3) Aspirate the supernatant, add 150 μL DMSO to each well, shake on a shaker in the dark for 10 minutes to fully dissolve the blue crystals.

[0022] (4) Measure the abso...

Embodiment 2

[0024] The influence of embodiment 2 gastrodin on cell activity

[0025] Drug Action Concentration Establishment:

[0026] (1) Collect HUVEC cells in the logarithmic phase. After the cells are 85% full, suck out the original medium, add 100 μL of 2 mmol / L Hcy solution and 100 μL of different drug concentration solutions in the experimental group, and add 200 μL of 0.5 mmol / L Hcy in the modeling group 150 μL of culture medium was added to the control group and the blank group.

[0027] (2) Incubated in 5% CO2, 37°C cell culture incubator for 24 hours, observed under an inverted microscope; 20 μL of MTT solution was added to each well, and cultured in a constant temperature incubator at 37°C for 4 hours.

[0028] (3) Aspirate the supernatant, add 150 μL DMSO to each well, shake on a shaker in the dark for 10 minutes to fully dissolve the blue crystals.

[0029] (4) Measure the absorbance of each well at a wavelength of 490 nm with a microplate reader.

[0030] Let the relativ...

Embodiment 3

[0031] The influence of embodiment 3 gastrodin on ROS

[0032] (1) Spread the cells on a 6-well plate. After the cells grow to about 70%, aspirate the original medium, add 1mL of 2mmol / L Hcy solution and 1mL of different drug concentration solutions in the experimental group, add 1mmol / L Hcy in the modeling group 2mL, the control group was added 2mL of culture medium, and the final volume of each well was 2mL.

[0033] (2) Incubated in 5% CO2, 37°C cell culture incubator for 24 hours, observed under an inverted microscope, sucked out the original medium, washed 3 times with pre-cooled PBS, added pre-cooled PBS containing 1 μmol / L DCFH-DA, 37 Incubate the cells at ℃ for 30 min.

[0034] (3) Aspirate the original PBS, wash with pre-cooled PBS 3 times, add 500 μL of paraformaldehyde, and place in a 37°C incubator for 15 minutes to fix.

[0035] (4) Pour off the paraformaldehyde, wash 3 times with pre-cooled PBS, and finally add 2 mL of pre-cooled PBS. Observe cells under a flu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses protection effect of natural monomer gastrodin on homocysteine induced human umbilical vein endothelial cell injury. Through pretreatment by homocysteine with a certain concentration, the human umbilical vein endothelial cell injury is induced; an injury model is built. On the basis of the model, the gastrodin is added; through cell activity detection, the effective concentration of the gastrodin protection cells is determined; the condition that the gastrodin protects the endothelial cells through eNOS / Cav-1 signal channels is determined through detecting the expression of ROS and p-eNOS / eNOS and Cav-1. The gastrodin is used for protecting the human umbilical vein endothelial cells for the first time, and the protection mechanism of the gastrodin is confirmed.

Description

technical field [0001] The invention belongs to the technical field of cell biology and pharmacology, specifically relates to the establishment of a human umbilical vein endothelial cell injury model, and particularly relates to the application of gastrodin in the preparation of a drug for protecting human umbilical vein endothelial cells. Background technique [0002] Hypertension is a common clinical disease and frequently-occurring disease. Its main complications include stroke, myocardial infarction and renal failure, which seriously endanger people's physical and mental health. It is one of the main factors of death from cardiovascular and cerebrovascular diseases. Since the incidence of hypertension is mostly determined by multiple factors such as genetics, environment, and biology, its incidence involves the disorder of material metabolism in the body and the lesions and dysfunctions of multiple systems and organs. A large number of antihypertensive drugs of Western m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7034A61P9/14
CPCA61K31/7034
Inventor 许激扬卞筱泓陈际宇史心悦杨青晨张怡静钟斯卉张真赫
Owner CHINA PHARM UNIV